Safer Metal Based Imaging Agents

更安全的金属基显像剂

基本信息

  • 批准号:
    10576181
  • 负责人:
  • 金额:
    $ 6.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary Metals offer a stunning array of properties that can be exploited for biomedical purposes. Metals such as platinum, ruthenium and copper are used in chemotherapy. Yttrium and indium are used in radiotherapy. Neodymium, europium and terbium are finding application in luminescent probes. Copper, gallium and whole host of other metal isotopes can be used in PET and SPECT imaging. Gadolinium is widely used in MRI, while manganese is proposed as an alternative. However, these advantageous properties come with a price: the risk of metal ion toxicity. To make metals safe for most in vivo application they must be held tightly in a coordinating ligand. The purpose of this ligand is to shield the body from the metal ion, avoiding the body’s natural metal transport and storage systems and permit the metallo-pharmaceutical to perform as intended. But most crucially this ligand allows the metal ion to be excreted. Broadly speaking, metals fall into one of two categories: 1) Those to which evolving life was exposed and took advantage: the essential minerals. And 2) those to which evolving life had no exposure and are not normally found in lifeforms: the xenobiotic metals (which includes many of the heavy metals). One might expect that these two classes of metal ion would be fundamentally different, but, they share a common feature in biology: neither can be excreted. Xenobiotic metals because these pathways never developed and essential minerals because they are too valuable to lose. Clearly metal ions escaping from the ligands in which they are administered represents a serious problem and risk to human health. Once out of the ligand they are incorporated into the body and can never leave. This means that the complexes formed between metal and ligand must be as robust as possible. Although there are some excellent ligand systems already in use in clinical medicine, concern continues to exist about the release of metal ions from these ligand structures. The aim of this small project is to investigate whether a small, and comparatively simple, modification to these ligand systems would lead to substantial improvements in the robustness of the complex. If so it will have the effect of paving the way to yet safer ligand systems for metals in biomedical applications.
项目摘要 金属提供了一系列令人惊叹的特性,可用于生物医学目的。金属如 铂、钌和铜用于化疗。钇和铟用于放射治疗。 钕、铕和铽在发光探针中得到应用。铜、镓和全 许多其它金属同位素可用于PET和SPECT成像。钆广泛用于MRI,而 锰被提议作为替代物。然而,这些有利的特性是有代价的:风险 金属离子毒性。 为了使金属在大多数体内应用中是安全的,它们必须紧紧地保持在配位配体中。目的 这种配体的作用是保护身体免受金属离子的侵害,避免身体自然的金属运输和储存 系统,并允许金属药物按预期发挥作用。但最关键的是,这种配体允许 金属离子被排出。 广义上说,金属可分为两类:1)进化中的生命接触和吸收的金属 优势:重要的矿物质。2)那些进化中的生命没有接触过的, 在生命形式中发现:异生金属(包括许多重金属)。人们可能会认为, 两类金属离子在本质上是不同的,但它们在生物学上有一个共同的特征: 可以排泄。异生物金属,因为这些途径从来没有开发和必需的矿物质, 他们太宝贵了,不能失去 显然,金属离子从它们所施用的配体中逃逸代表了严重的问题, 对人类健康的风险。一旦离开配体,它们就被纳入体内,永远不能离开。这 这意味着金属和配体之间形成的络合物必须尽可能坚固。虽然有 一些优秀的配体系统已经在临床医学中使用,关于释放的担忧继续存在 这些配体结构中的金属离子。这个小项目的目的是调查一个小的, 相对简单的,对这些配体系统的修饰将导致在生物活性方面的实质性改善。 复杂的鲁棒性。如果是这样的话,它将为更安全的金属配体系统铺平道路 在生物医学应用中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK WOODS其他文献

MARK WOODS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK WOODS', 18)}}的其他基金

Safer Metal Based Imaging Agents
更安全的金属基显像剂
  • 批准号:
    10709659
  • 财政年份:
    2022
  • 资助金额:
    $ 6.94万
  • 项目类别:
Improving the Effectiveness of ParaCEST Agents by Controlling the Conformation
通过控制构象提高 ParaCEST 药物的有效性
  • 批准号:
    8033175
  • 财政年份:
    2010
  • 资助金额:
    $ 6.94万
  • 项目类别:
Improving the Effectiveness of ParaCEST Agents by Controlling the Conformation
通过控制构象提高 ParaCEST 药物的有效性
  • 批准号:
    7874779
  • 财政年份:
    2010
  • 资助金额:
    $ 6.94万
  • 项目类别:
TOWARDS A SINGLE INJECTION METHOD OF DETERMINING IN VIVO PH BY MRI
通过 MRI 确定体内 PH 值的单次注射方法
  • 批准号:
    7357912
  • 财政年份:
    2006
  • 资助金额:
    $ 6.94万
  • 项目类别:
Rational control of water exchange in Gd3+ complexes
Gd3配合物中水交换的合理控制
  • 批准号:
    6783808
  • 财政年份:
    2004
  • 资助金额:
    $ 6.94万
  • 项目类别:
Rational control of water exchange in Gd3+ complexes
Gd3配合物中水交换的合理控制
  • 批准号:
    6864434
  • 财政年份:
    2004
  • 资助金额:
    $ 6.94万
  • 项目类别:
Copper Complexes for Cancer Imaging and Therapy
用于癌症成像和治疗的铜配合物
  • 批准号:
    6687219
  • 财政年份:
    2003
  • 资助金额:
    $ 6.94万
  • 项目类别:

相似国自然基金

Journal of Integrative Plant Biology
  • 批准号:
    31024801
  • 批准年份:
    2010
  • 资助金额:
    24.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

An engineering biology approach for sustainable production of omega 3 and pigments from microalgae
一种利用微藻可持续生产 omega 3 和色素的工程生物学方法
  • 批准号:
    10107393
  • 财政年份:
    2024
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Launchpad
FLF Next generation atomistic modelling for medicinal chemistry and biology
FLF 下一代药物化学和生物学原子建模
  • 批准号:
    MR/Y019601/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Fellowship
Sustainable Style for Clean Growth: Innovating Textile Production through Engineering Biology
清洁增长的可持续方式:通过工程生物学创新纺织品生产
  • 批准号:
    BB/Y007735/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Research Grant
Preventing Plastic Pollution with Engineering Biology (P3EB) Mission Hub
利用工程生物学 (P3EB) 任务中心预防塑料污染
  • 批准号:
    BB/Y007972/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Research Grant
GlycoCell Engineering Biology Mission Hub: Transforming glycan biomanufacture for health
GlycoCell 工程生物学任务中心:转变聚糖生物制造以促进健康
  • 批准号:
    BB/Y008472/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Research Grant
Postdoctoral Fellowship: STEMEdIPRF: Understanding instructor and student concepts of race to measure the prevalence of race essentialism in biology education
博士后奖学金:STEMEdIPRF:了解教师和学生的种族概念,以衡量生物教育中种族本质主义的流行程度
  • 批准号:
    2327488
  • 财政年份:
    2024
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Standard Grant
CAREER: Hybridization and radiation: Integrating across phylogenomics, ancestral niche evolution, and pollination biology
职业:杂交和辐射:系统基因组学、祖先生态位进化和授粉生物学的整合
  • 批准号:
    2337784
  • 财政年份:
    2024
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Continuing Grant
Collaborative Research: IMPLEMENTATION: Broadening participation of marginalized individuals to transform SABER and biology education
合作研究:实施:扩大边缘化个人的参与,以改变 SABER 和生物教育
  • 批准号:
    2334954
  • 财政年份:
    2024
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Standard Grant
Collaborative Research: REU Site: Summer Undergraduate Research Program in RNA and Genome Biology (REU-RGB)
合作研究:REU 网站:RNA 和基因组生物学暑期本科生研究计划 (REU-RGB)
  • 批准号:
    2349255
  • 财政年份:
    2024
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Continuing Grant
REU Site: Nature's machinery through the prism of Physics, Biology, Chemistry and Engineering
REU 网站:通过物理、生物、化学和工程学的棱镜观察自然的机器
  • 批准号:
    2349368
  • 财政年份:
    2024
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了